drugset / Trial / NCT00896207

Studying Different Formulations of SR13668 in Healthy Volunteers

NCT00896207 ↗

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized early phase I trial is studying different formulations of SR13668 in healthy volunteers. Giving SR13668 may help doctors learn more about how SR13668 is used by the body. It is not yet known which formulation of SR13668 is most effectively used by the body.

Timeline

Start
2009-06
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject SR13668 Small molecule — Oral

Indications

No indication recorded.